Citius licenses Novellus' iPSC-derived mesenchymal stem cells for acute respiratory conditions Oct. 9, 2020
Caladrius initiates proof-of-concept study of CLBS-119 for repair of COVID-19-induced lung damage Oct. 9, 2020
FDA clears IND for study of inhaled Ampion in COVID-19 patients with respiratory distress Sep. 22, 2020
RSS